By Lu Wang
July 28 (Bloomberg) -- Shares of the following companies may have unusual moves in U.S. trading. Stock symbols are in parentheses.
Amgen Inc. (AMGN US): The world’s largest biotechnology company boosted its full-year earnings forecast after second- quarter profit topped analysts’ estimates.
Health Management Associates Inc. (HMA US): The operator of acute care hospitals increased its full-year profit forecast to 45 cents a share or more. The average analyst estimate in a Bloomberg survey was for profit of 42 cents.
Masco Corp. (MAS US): The insulation installer forecast a loss this year of as little as 5 cents a share, compared with the average analyst loss estimate of 26 cents.
Medicis Pharmaceutical Corp. (MRX US): The drugmaker said the U.S. Food and Drug Administration will allow it to sell two more doses of its Solodyn acne treatment.
Veeco Instruments Inc. (VECO US): The maker of gear for chipmakers and data storage forecast full-year sales of at least $310 million, beating the average analyst estimate of $281.2 million.
To contact the reporter on this story: Lu Wang in New York at lwang8@bloomberg.net.
Posts
No comments:
Post a Comment